WWFHTX is a grassroots initiative that unites health consumers, biopharmaceutical company employees vendors, suppliers, academic and community partners.
Texas
Joined April 2013
- Tweets5.5K
- Following788
- Followers391
- Likes2K
Pinned Tweet
The prescription drug supply chain, including #PBMs, is now making more money off of those #medicines than the #biopharma companies that developed them. thinkbrg.com/insights/public… @txhbi From: Berkeley Research Group #BRG
Why Houston continues to lead as a #biopharma #innovation hub and #clinicaltrials pacesetter. @txhbi axios.com/local/houston/spon…
With the #340B Rebate Model Pilot program, 340B facilities must request rebates instead of receiving upfront discounts on drugs sold by 10 participating drugmakers. #340BReform @IAFAccess tinyurl.com/4t7e2a8s
Read why 350+ patients are urging policymakers to reject #MostFavoredNation drug pricing policy for the U.S. @TXDisabilities nopatientleftbehind.org/medi…
The federal #340B program, meant to help safety-net hospitals, now gives hospitals financial reasons to overuse expensive drugs and expand through consolidation. @TPPF medicaldaily.com/hhs-340b-an…
“HRSA’s new rebate approach doesn’t solve the larger #340B problem, but it introduces something the program badly needs – verifiable information at the transaction level.” #340BReform @IAFAccess thewellnews.com/opinions/rig…
United #Healthcare credits Q3 profits to “benefit design changes” & “pricing discipline,” meaning enrollees are paying more and getting less #healthinsurance. @StopAfib healthcareuncovered.substack…
“Many #340B hospitals . . . have strong financial incentives to steer patients toward higher-cost drugs that generate larger profit margins.” #340BReform @TXDisabilities realclearhealth.com/articles…
Read why new @BRGexpert report on #340B hospitals underscores the urgency for Congress to enact #340BReform. @TCCRI cagw.org/new-report-finds-34…
Patients care re: today’s out-of-pocket medicine costs. They also care whether a better treatment will exist 5-10 years from now. Sound policy must account for both. #MostFavoredNation cannot. truthonthemarket.com/2026/10…
Per @HHSGov policy heads, the controversial #340B program has grown beyond its original intent while doing little to better serve patients. #340BReform @BioNorthTX fiercehealthcare.com/regulat…
Why former TX Congressman @michaelcburgess was surprised, yet gratified, to see both parties in Congress agreeing to pursue needed #healthinsurance reform. @txhbi nationalreview.com/2026/10/i…
Instead of implementing #MostFavoredNation #drugpricing, the U.S. should make other countries pay their fair share for the medicines America develops. @NTxCommission foxnews.com/opinion/trump-lo…
Read from @TPPF how #HealthInsurance – #PBM conglomerates increase #healthcare costs. texaspolicy.com/how-middleme…
Approved, revised #340B rebate pilot program to shift discounts on drugs from upfront savings to back-end rebates. #340BReform @TPPF healthcaredive.com/news/340b…
#Drugpricing models like #MostFavoredNation could set up new barriers to #healthcare and worsen health outcomes. @TCCRI state-journal.com/2026/09/21…
Check out @weworkforhealth blog on importance of strong #IP and #IPRights for US life sciences leadership. @BioNorthTX weworkforhealth.org/post/250…
Learn how – with nearly 2,700 subsidiaries & affiliated entities – one #HealthInsurance company has embedded itself across the U.S. #healthcare system. @StopAfib healthcareuncovered.substack…
Half of #healthinsurance denials get reversed. So why deny them in the 1st place? New data shows patients who appeal #priorauthorization denials win about half the time. @StopAfib healthcareuncovered.substack…?
Some say a lack of consistent investment funding is a major factor holding U.S. #biotech back, as China rises. @BioNorthTX biospace.com/business/chinas…
